Fundraising Foxperiotherapia
Osaka, JP · 2 known investors
Find your way into periotherapia
Sign up to see every warm intro you have to periotherapia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the periotherapia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.
Founders & leadership
YT
Yoshiaki TaniyamaDirector and Founder
ET
Eiji TaharaRepresentative Director, President, CEO and COO
Investors · 2
Frequently asked questions
- What does periotherapia do?
- Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.
- Who founded periotherapia?
- periotherapia was founded by Yoshiaki Taniyama.
- Who are periotherapia's investors?
- periotherapia's investors include Chishima Real Estate — Startup Investment, Eisai Innovation, Inc..
- Where is periotherapia headquartered?
- periotherapia is headquartered in Osaka, JP.